[1]
AROCKYASAMY, A.S. et al. 2026. MOLECULAR AND FUNCTIONAL VALIDATION OF POMIFERIN AS A POTENTIAL ANTIDIABETIC AGENT: IN VITRO AND IN SILICO EVIDENCE TARGETING INSULIN SIGNALING PATHWAYS. International Journal of Applied Pharmaceutics. 18, 4 (Apr. 2026). DOI:https://doi.org/10.22159/ijap.2026v18i4.58826.